Hadasit and Oramed Pharmaceuticals Collaborate for Development of Oral Delivery System Technology
Hadasit, the Hadassah
University Medical Center’s technology transfer company, has signed a contract
with Oramed Pharmaceuticals to continue working together on the development of
Oramed’s platform technology for the oral delivery of medicine, such as
Hadassah Celebrates 36th Class of International Public Health Graduates
Nineteen students from countries as diverse
as Ethiopia and China were graduated this year from the International Masters
in Public Health Program (IMPH) of the Hadassah-Hebrew University Braun School
of Public Health.
Hadassah University Medical Center’s Prof. Jacque Michel Honored for 10 Years as Head of Helsinki Committee
Prof. Jacque Michel, former
Director of Hadassah Hospital-Mount Scopus and Volunteer Chair of the Hadassah
University Medical Center’s Helsinki Committee for the past 10 years, was
honored by Hadassah during a special seminar on Ethics in Medicine.
Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells
Since 1990, the
Multiple Sclerosis (MS) Center at the Hadassah University Medical Center has
been conducting groundbreaking research into the use of bone marrow-derived
stem cells to treat MS. Today, Hadassah’s MS Center, headed by Prof. Dimitrios Karussis,
is a world leader in treating MS with
Honors for Hadassah University Medical Center Intensive Care Pioneer
Prof. Charles Sprung, Director of the Intensive Care Unit at Hadassah Hospital-Ein Kerem, has been honored by The European Society of Intensive Care Medicine (ESICM) with the Society's 2011 Medal, its most prestigious award. In his letter to Prof. Sprung, President Andrew Rhodes wrote: "Your leadership has changed the way intensive care medicine is viewed and has led to significant advances and improvements in the standards of care."
Israel’s President Shimon Peres Toasts Hadassah as a Role Model for Peacemaking
"No institution models a place of complete peace under the most demanding circumstances more than Hadassah," Israel's President Shimon Peres said at a special September reception welcoming the new Hadassah National President Marcie Natan.
Researchers Identify Gene Involved in Ovarian Development
A teenage girl who came to the Hadassah University Medical Center for help when she did not go through puberty, led to the discovery of a gene that plays a major role in ovarian development. The three-year investigation was conducted by a joint team from Hadassah and Shaare Zedek Medical Center, led by Dr. David Zangen, head of Hadassah’s Pediatric Endocrinology Unit, and Prof. Ephrat Levy-Lahad, head of the Medical Genetics Institute at Shaare Zedek.
Spotlight on Hadassah’s Dr. Yael Houri-Haddad: Specialist in Oral Biology
Yael Houri-Haddad, who immigrated to Israel
from Tunisia at age 14, is a Hadassah University Medical Center dentist with a
PhD in oral biology. She acquired both specialties at Hadassah where she now
teaches, treats patients, and conducts research in the Department
of Prosthodontics at the Hadassah Hebrew University School of Dental
The Call Every Parent Dreads: the Story of a Car Accident, Hadassah Trauma Expertise, and a Happy Ending
"I knew it was bad when I
saw my wife's knees buckle and her hand grasped the wall for support. Our son
Yaakov, 21, was hit by a car," relates Ephraim Shore, a well-known
educator at the Aish HaTorah Yeshiva in Jerusalem.
Artist who Severed His Hand Has Ability to Paint Again Thanks to Hadassah University Medical Center
Although he severely
severed the palm of his hand, Sa'ad El-Kikh, an artist from the village of
Tsurif near Hebron, is able to draw and paint once again thanks to a special
tool affixed to his hand by Hadassah University Medical Center physical
Clinical Trial at Hadassah Hospital Yields Positive Results With Noninvasive Test for Liver Cancer
A clinical trial conducted at the Hadassah University Medical Center has revealed that BreathID, a new noninvasive device for the detection of hepato-cellular carcinoma, a type of liver cancer, achieved diagnostic results similar to CT Scans and MRIs. BreathID was developed by Exalenz Bioscience Ltd., whose Medical Director is Prof. Yaron Ilan, Director of Hadassah's Department of Internal Medicine.
Clinical Trial Begins at Hadassah University Medical Center with New Drug to Treat Stroke
A Phase IIa clinical trial with a medicine to treat ischemic stroke has begun at Hadassah, based on the research of Prof. Abd Al-Roof Higazi, head of the Department of Clinical Biochemistry at Ein-Kerem.
Diabetes Cure Moves a Step Closer with new Hadassah/Hebrew University Research
Hope for a future cure of insulin-dependent (type 1) diabetes received a boost from the research findings of a multi-year project. Read about it
Hadassah Medical Center Professor Elected "Director at Large" for Prestigious Radiopharmaceutical Society
Prof. Eyal Mishani, who established Hadassah's Cyclotron Radiochemistry Unit, was elected to serve as "Director at Large" on the five-member Executive of the Society of Radiopharmaceutical Sciences (SRS).
Hadassah Medical School Graduate Named Chief Executive Officer of Harvard’s Teaching Hospital--Beth Israel Deaconess Medical Center
Dr. Kevin Tabb, a graduate of the Hadassah-Hebrew University School of Medicine, is the new President and CEO of Beth Israel Deaconess Medical Center, the teaching hospital of Harvard University.
Hadassah Physician Predicts Use of Medical Marijuana Will Grow
The number of authorizations for medical marijuana could reach as high as 40,000 in the next five years, predicts Dr. Elyad Davidson of the Hadassah University Medical Center's Pain Management Clinic.
Hadassah’s Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration
Hadassah's Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration Hadassah's National Physicians Council will be hosting a pre-Centennial Convention Continuing Education Program in Jerusalem, Oct. 14-15, 2012.
Liver Disease Early Diagnosis Device Developed at Hadassah Medical Center Receives Exemption from FDA, Providing Fast Track for Approval
BreathID, a noninvasive early diagnosis device for acute liver failure developed at the Hadassah University Medical Center, has been fast-tracked by the FDA toward approval.
Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome
"In pre-clinical studies," notes Prof. Raphael Gorodetsky, head of the Biotechnology and Radiobiology Laboratory at the Sharrett Institute of Oncology at Hadassah University Medical Center, "we found that placental-derived cells potentially have the ability to increase the survival rate of animals following exposure to lethal doses of total body irradiation."
Reunion at Hadassah Commemorates Saving of Life by Organ Recipient Families who Later Became Organ Donors
Three families whose lives were intertwined by organ transplantation reunited recently at Hadassah University Medical Center to commemorate the saving of life following the tragic death of loved ones.